Clinical trial

Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD

NCT01920672

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention Timed Planned Activity Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Home Safety and Education Program Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-09-01

PhaseNA

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

Timed Planned ActivityBEHAVIORAL

Home Safety and Education ProgramBEHAVIORAL

Sponsors & collaborators

Johns Hopkins Universitylead sponsor

National Institute of Nursing Research (NINR)collaborator

Mapped research locations

BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01920672 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.